These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Effect of the quaternary ammonium salts of the monodisperse oligomers of conidine on a mast cell population]. Efimov VS, Poberiĭ IA, Chernova OV, Pereverzev AI. Farmakol Toksikol; 1984; 47(6):50-3. PubMed ID: 6519256 [Abstract] [Full Text] [Related]
3. [Interaction of the calcium salt of heparin with specific antagonists and ethacizine]. Ushkalova EA, Petrov AD, Kremneva VF, Shcheglova NV. Farmakol Toksikol; 1988; 51(6):53-6. PubMed ID: 3234542 [Abstract] [Full Text] [Related]
4. Reversal of protamine of the prolonged response to intrapulmonary heparin. Wright CJ, Mahadoo J, Jaques LB. Can J Surg; 1981 Mar; 24(2):130-2. PubMed ID: 7225967 [Abstract] [Full Text] [Related]
6. [Experimental study of the heparin antagonist protamine chloride]. Efimov VS. Farmakol Toksikol; 1968 Mar; 31(5):601-4. PubMed ID: 5707736 [No Abstract] [Full Text] [Related]
7. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate. Maddineni J, Hoppensteadt DA, Cornelli U, Manoni M, Fareed J. Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496 [Abstract] [Full Text] [Related]
8. [Protamine complexes with antithrombin III and heparin]. Roszkowska W, Worowski K. Acta Haematol Pol; 1982 Jan; 13(1-2):25-8. PubMed ID: 7180353 [No Abstract] [Full Text] [Related]
9. Studies on the anticoagulant action of heparin, protamine, and Polybrene in the activation of factor IX. Shanberge JN, Fukui H. J Lab Clin Med; 1967 Jun; 69(6):927-37. PubMed ID: 6025496 [No Abstract] [Full Text] [Related]
13. Reversal of heparin-induced increases in aPTT in the rat by PM102, a novel heparin antagonist. Cushing DJ, Cooper WD, Cohen ML, McVoy JR, Sobel M, Harris RB. Eur J Pharmacol; 2010 Jun 10; 635(1-3):165-70. PubMed ID: 20307530 [Abstract] [Full Text] [Related]
17. Interaction studies with metolazone, heparin and protamine sulfate. Yelnosky J, Borrelli A, Kaiser F, Belair E. Arch Int Pharmacodyn Ther; 1973 Jul 10; 204(1):5-11. PubMed ID: 4746632 [No Abstract] [Full Text] [Related]
18. [In vitro and in vivo neutralisation of a low molecular weight heparin fraction CY 216 by protamine]. Doutremepuich C, Bonini F, Masse A, Bousquet F, Bayrou B, Toulemonde F. Ann Pharm Fr; 1986 Jul 10; 44(1):65-72. PubMed ID: 3777780 [No Abstract] [Full Text] [Related]